Zhong, Y <br/><br/>
Selinexor suppresses downstream effectors of B-cell activation, proliferation and migration in chronic lymphocytic leukemia cells.  [electronic resource] 

 -  Leukemia  May 2014 
 - 1158-63 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1476-5551 
<br/><br/><label>Standard No.: </label>10.1038/leu.2014.9  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>B-Lymphocytes--drug effects<br/>Cell Movement--drug effects<br/>Cell Proliferation--drug effects<br/>Humans<br/>Hydrazines--pharmacology<br/>Leukemia, Lymphocytic, Chronic, B-Cell--immunology<br/>Lymphocyte Activation--drug effects<br/>Triazoles--pharmacology